Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (221-230 of 544) with videos related to

Pageof 55
Sort By:
Breast Cancer Research and Treatment|April 26, 2013
Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance programPål Møller, Astrid Stormorken, Christoffer Jonsrud, et al.
Gynecologic Oncology|July 7, 2009
Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriersDanielle Vicus, Barry Rosen, Jan Lubinski, et al.
Gynecologic Oncology|September 12, 2006
The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective studyMario E Beiner, Amy Finch, Barry Rosen, et al.
Breast Cancer Research and Treatment|December 6, 2018
A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their familiesTalia Donenberg, Sophia George, Jameel Ali, et al.
International Journal of Cancer|March 29, 2002
BRCA1 and BRCA2 mutations among breast cancer patients from the PhilippinesMaria Lourdes De Leon Matsuda, Alexander Liede, Elaine Kwan, et al.
NPJ Precision Oncology|June 22, 2022
An appraisal of genetic testing for prostate cancer susceptibilityAmy Finch, Roderick Clark, Danny Vesprini, et al.
Menopause (New York, N.Y.)|August 16, 2020
Factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriersJavier Mejia-Gomez, Jacek Gronwald, Leigha Senter, et al.
Breast Cancer Research and Treatment|November 30, 2021
Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioningKelly A Metcalfe, Andrea Eisen, Frances Wright, et al.
Breast Cancer Research and Treatment|October 27, 2012
The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancerMohammad R Akbari, Wojciech Kluźniak, Rachelle Rodin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 28, 2023
Correlates of Circulating Osteoprotegerin in Women with a Pathogenic or Likely Pathogenic Variant in the BRCA1 GeneSarah Sohyun Park, Tasnim Zaman, Shana J Kim, et al.
Pageof 55

Showing results (221-230 of 544) with videos related to

Sort By:
Pageof 55
Breast Cancer Research and Treatment|April 26, 2013
Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance programPål Møller, Astrid Stormorken, Christoffer Jonsrud, et al.
Gynecologic Oncology|July 7, 2009
Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriersDanielle Vicus, Barry Rosen, Jan Lubinski, et al.
Gynecologic Oncology|September 12, 2006
The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective studyMario E Beiner, Amy Finch, Barry Rosen, et al.
Breast Cancer Research and Treatment|December 6, 2018
A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their familiesTalia Donenberg, Sophia George, Jameel Ali, et al.
International Journal of Cancer|March 29, 2002
BRCA1 and BRCA2 mutations among breast cancer patients from the PhilippinesMaria Lourdes De Leon Matsuda, Alexander Liede, Elaine Kwan, et al.
NPJ Precision Oncology|June 22, 2022
An appraisal of genetic testing for prostate cancer susceptibilityAmy Finch, Roderick Clark, Danny Vesprini, et al.
Menopause (New York, N.Y.)|August 16, 2020
Factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriersJavier Mejia-Gomez, Jacek Gronwald, Leigha Senter, et al.
Breast Cancer Research and Treatment|November 30, 2021
Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioningKelly A Metcalfe, Andrea Eisen, Frances Wright, et al.
Breast Cancer Research and Treatment|October 27, 2012
The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancerMohammad R Akbari, Wojciech Kluźniak, Rachelle Rodin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 28, 2023
Correlates of Circulating Osteoprotegerin in Women with a Pathogenic or Likely Pathogenic Variant in the BRCA1 GeneSarah Sohyun Park, Tasnim Zaman, Shana J Kim, et al.
Pageof 55